drugset / Trial / NCT04173364

Interscalene Block and Dysfunction Diaphragmatic

NCT04173364

Phase 3 Completed 60 enrolled University Hospital, Lille
RandomizedParallel-groupDouble-blindTreatment

Summary

The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.

Timeline

Start
2019-10-29
Primary completion
2020-09-21
Completion
2020-09-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.1 % Other
Comparator Ropivacaine Other / unclassified 0.5 % Other

Indications